Announcements
- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
On Friday, Immutep Ltd (YP1B:MUN) closed at 0.252, -11.07% below its 52-week high of 0.2834, set on May 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.252 |
---|---|
High | 0.252 |
Low | 0.252 |
Bid | 0.244 |
Offer | 0.264 |
Previous close | 0.252 |
Average volume | 7.22k |
---|---|
Shares outstanding | 1.50bn |
Free float | 1.46bn |
P/E (TTM) | -- |
Market cap | 614.53m AUD |
EPS (TTM) | -0.039 AUD |
Data delayed at least 15 minutes, as of Jun 14 2024 07:05 BST.
More ▼